| Online-Ressource |
Verfasst von: | Riedel, Fabian [VerfasserIn]  |
| Heil, Jörg [VerfasserIn]  |
| Feißt, Manuel [VerfasserIn]  |
| Moderow, Mareike [VerfasserIn]  |
| Au, Alexandra von [VerfasserIn]  |
| Domschke, Christoph [VerfasserIn]  |
| Michel, Laura L. [VerfasserIn]  |
| Schäfgen, Benedikt [VerfasserIn]  |
| Golatta, Michael [VerfasserIn]  |
| Hennigs, André [VerfasserIn]  |
Titel: | Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy |
Verf.angabe: | Fabian Riedel, Joerg Heil, Manuel Feisst, Mareike Moderow, Alexandra von Au, Christoph Domschke, Laura Michel, Benedikt Schaefgen, Michael Golatta, André Hennigs |
E-Jahr: | 2020 |
Jahr: | 20 August 2020 |
Umfang: | 10 S. |
Fussnoten: | Gesehen am 12.08.2021 |
Titel Quelle: | Enthalten in: Breast cancer research and treatment |
Ort Quelle: | Dordrecht [u.a.] : Springer Science + Business Media B.V., 1981 |
Jahr Quelle: | 2020 |
Band/Heft Quelle: | 184(2020), 2, Seite 627-636 |
ISSN Quelle: | 1573-7217 |
Abstract: | In the ACOSOG Z0011 trial, completing axillary lymph node dissection (cALND) did not benefit patients with T1-T2 cN0 early breast cancer and 1-2 positive sentinel lymph nodes (SLN) undergoing breast-conserving surgery (BCT). This paper reports cALND rates in the clinical routine for patients who had higher (T3-T4) tumor stages and/or underwent mastectomy but otherwise met the ACOSOG Z0011 eligibility criteria. Aim of this study is to determine cALND time trends and non-sentinel axillary metastases (NSAM) rates to estimate occult axillary tumor burden. |
DOI: | doi:10.1007/s10549-020-05876-z |
URL: | kostenfrei: Volltext: https://doi.org/10.1007/s10549-020-05876-z |
| DOI: https://doi.org/10.1007/s10549-020-05876-z |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1766555292 |
Verknüpfungen: | → Zeitschrift |
|
|
| |
Lokale URL UB: | Zum Volltext |
Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy / Riedel, Fabian [VerfasserIn]; 20 August 2020 (Online-Ressource)